CRVS·221015100·US·equity·Healthcare - Biotechnology-Activist
CRVS (CORVUS PHARMACEUTICALS INC) is held by 70 institutional investors as of Q4 2025. Largest holders: BlackRock, Inc. ($38.9M), VANGUARD GROUP INC ($29.8M), MORGAN STANLEY ($27.5M). Net institutional sentiment: Bullish.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer